From Mendel to Gene Therapy

Samantha L Jeffrey; Don A Brigham; Sant P Chawla; Noah Federman; Frederick L Hall; Erlinda M Gordon

doi:10.21873/anticanres.16620

From Mendel to Gene Therapy

Anticancer Res. 2023 Oct;43(10):4257-4261. doi: 10.21873/anticanres.16620.

Authors

Samantha L Jeffrey¹, Don A Brigham², Sant P Chawla³, Noah Federman¹, Frederick L Hall², Erlinda M Gordon^{4

3}

Affiliations

¹ University of California, Los Angeles, CA, U.S.A.
² Aveni Foundation, Santa Monica, CA, U.S.A.
³ Cancer Center of Southern California/Sarcoma Oncology Research Center, Santa Monica, CA, U.S.A.
⁴ Aveni Foundation, Santa Monica, CA, U.S.A.; egordon@sarcomaoncology.com.

PMID: 37772566
DOI: 10.21873/anticanres.16620

No abstract available

Keywords: CAR-T cell therapy; DeltaRex-G; Gregor Mendel; Holy Grail of Gene Therapy; Watson & Crick; adenoassociated vector; gene therapy; human genome project; retroviral vector; targeted gene delivery.

Publication types

Letter